Phase III SafeHer study subgroup analyses: Safety and tolerability of subcutaneous trastuzumab for HER2-positive early breast cancer in patients with lower body weight and in Asian patients
| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | Phase III SafeHer study subgroup analyses: Safety and tolerability of subcutaneous trastuzumab for HER2-positive early breast cancer in patients with lower body weight and in Asian patients |
| Type de publication | Journal Article |
| Year of Publication | 2015 |
| Auteurs | Shing M., Jung K.H, Ataseven B., Verrill M., De Laurentiis M., Azim H.A, Pivot X., Al-Sakaff N., Lauer S., Gligorov J. |
| Journal | ANNALS OF ONCOLOGY |
| Volume | 26 |
| Pagination | 19-20 |
| Date Published | DEC |
| Type of Article | Meeting Abstract |
| ISSN | 0923-7534 |